Thailand Legal Cannabis Market Likely To Touch At $9.6 Billion By 2030: Grand View Research Inc.
The Thailand legal cannabis market size is expected to reach USD 9.6 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 58.4% from 2022 to 2030. The growth is attributed to the rising usage of cannabis for recreational and medical purposes. Cannabis legalization has opened new revenue-generating opportunities for various industries in the country. The adoption of CBD oil and tinctures for treating various ailments like nausea, anxiety, and cancer along with the rising prevalence of cancer are some of the significant factors boosting the industry’s growth.
The growing burden of chronic pain has
also augmented the rise in the usage of CBD for treatments related to pain
management and thus, positively impacting the market growth. Various studies
have shown positive outcomes of marijuana and its derivatives to treat symptoms
of several chronic conditions. For instance, it has been effectively used to
treat patients dealing with chronic pain, nausea induced by chemotherapy, and
neurological diseases such as Alzheimer’s and Parkinson’s. Hence, FDA and other
government organizations are permitting marijuana derivatives for the
prescription of several diseases. This is one of the key factors for the quick
turnaround.
In 2018, Thailand legalized the
adoption of cannabis for medical purposes. Furthermore, in June 2022, the
government decriminalized the distribution, cultivation, consumption, and
marketing of all the parts of the cannabis plant. The Thai Food and Drug Administration
has also removed the cannabis plant from the Category 5 narcotics list.
Although, smoking cannabis in public areas is still illegal.
Furthermore, the rising disposable
income of the country, increasing healthcare expenditure, a surge in social
acceptance of CBD for its therapeutic applications, and an increasing number of
product launches, along with improvements in intellectual property rights of
Thailand are some of the key reasons that are expected to fuel the business
growth.
Moreover, with this legalization, more
domestic players are planning to explore the CBD market and key players are
also planning strategic initiatives to expand their product portfolio and
regional domination through mergers & acquisitions, collaborations, partnerships,
funding & investments. For instance, in December 2020, Tilray Brand s Inc.
merged with Aphria and will operate under the name Tilray. Such factors also
fuel the industry’s growth. The growing trend of cannabis-infused food and
beverages and the rising adoption of CBD oil by cosmetics and wellness
industries also boost the industry’s growth within the country.
To Request Sample Copy of this report, click the link:
Some of the most common conditions
where cannabis is used are: for treating malignant or non-malignant tumors,
musculoskeletal disorders such as weakness, spasm, pain or rigidity, and
neuropsychiatric disorders. Some other instances where cannabis is used for
treatment such asthma, HIV-AIDS, herpes zoster, hypercholesterolemia,
hypertension, and others.
According to the Committee for Public
Relations on Medical Cannabis of the Ministry of Public Health, in 2021,
Thailand had about 800 medical marijuana clinics and Thai traditional medical
marijuana clinics under the Ministry of Public Health. Furthermore, on March
2021, 64 clinics and 22 hospitals received medical marijuana licenses from the
Food and Drug Administration. Thus, positively impacting the market growth.
Thailand Legal
Cannabis Market Report Highlights
- The hemp segment dominated the Thailand
legal cannabis industry in 2021 and accounted for the largest revenue
share of 88.4%. Growing usage of hemp for industrial purposes is one of
the key factors fueling the segment’s growth
- The CBD segment held the largest revenue
share of about 68.4% in 2021. The growth of the segment is attributed to
the rising acceptance of CBD by consumers. However, the THC segment is
expected to grow at the fastest CAGR of 61.4%
- In 2021, the industrial segment held the
largest revenue share at 81.9%. Growing adoption of CBD by various
industries such as wellness and cosmetics, food and beverages, and others
are projected to boost the segment’s growth
In 2018, Thailand legalized cannabis
for medical purposes and by June 2022, the government decriminalized the
distribution, cultivation, consumption, and marketing of all the parts of the
cannabis plant. Due to this decriminalization, about 4,200 prisoners were
released. Since then, the Thai Food and Drug Administration has also removed
the cannabis plant from the Category 5 narcotics list. However, under the
Public Health Act, smoking cannabis in a public area can lead to three months
of jail and a fine of USD ~800.
Although, cafes and restaurants are
allowed to serve cannabis-infused drinks and food, only if the THC content is
limited to 0.2%. Furthermore, to mark the new rule of allowing cannabis
production and planning to use cannabis as a crash crop, on 8th May
2022, Thailand’s health minister “Anutin Charnvirakul” posted on its Facebook
wall that the Thailand government will distribute 1 million free cannabis
plants to households throughout the country, which started on June 9, 2022.
A growing number of CBD-related
R&D activities by government organizations, NGOs, private companies, and
universities further drives the market growth. The growing healthcare sector
within the country is one of the key factors that is increasing the usage of
medical cannabis. The healthcare expenditure of Thailand is expected to grow to
USD 50 billion by 2026 and the country is also the third most visited medical
tourism destination. Thus, fueling the market growth.
Like other industries, the ongoing
Covid-19 pandemic had negatively impacted the legal cannabis market. The graph
of the legal cannabis industry in Thailand declined from 2022 to 2020, as due
to lock down, most of the places were shut down and no industrial movements
were taking place which hampered the market during that period. Most
importantly, major supply chain disruptions in the cannabis industry and a
decline in the research work related to CBD led to a decline in growth.
List of Key
Players in the Thailand Legal Cannabis Market
- PharmaHemp
- MediPharm Labs, Inc.
- Cresco Labs
- Elixinol Thailand Limited
- Tilray
- Extractas
- BOL Pharma
- Canopy Growth Corporation
- THC Thailand Group Ltd.
Comments
Post a Comment